A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
This research study, called ATTAIN-Hypertension, is investigating a new medication, orforglipron, for adults who have high blood pressure and are also overweight or living with obesity. The main goal is to find out if orforglipron is effective in lowering blood pressure and to check how safe it is for people to use. Participants will be randomly assigned to either receive the new medicine or a 'dummy' pill (placebo) that looks the same but contains no active drug. This is a common way to test new treatments, helping researchers understand the medicine's true effects. It's part of a larger research programme looking into orforglipron.
Em resumo
Sobre o que é este estudo?
This study, known as ATTAIN-Hypertension, is a clinical trial focused on a new medicine called orforglipron (which has a code name LY3502970). The main purpose of this research is to see if orforglipron can help people who have high blood pressure, especially if they are also overweight or living with obesity. High blood pressure can lead to serious health problems like heart attacks and strokes, so finding effective treatments is very important.
Researchers want to understand two key things: first, if orforglipron actually works to lower blood pressure in this group of people (this is called its 'efficacy'), and second, whether it is safe to use and what side effects it might have (this is called its 'safety'). To do this, some people in the study will receive orforglipron, while others will receive a 'placebo', which looks identical but doesn't contain any active medicine. This allows doctors to compare the results and see if the new medicine is having a real effect.
This specific study is part of a bigger research effort investigating orforglipron. By participating, you would be helping medical science learn more about how to treat high blood pressure in people who also struggle with their weight, potentially leading to new treatment options in the future.
Pontos principais
- The study is testing a new medicine, orforglipron, for high blood pressure.
- It's for adults who also have obesity or are overweight.
- The goal is to check how well the medicine works and if it's safe.
- Some participants will get the actual medicine, others a dummy pill.
- A participação envolve visitas regulares à clínica e exames de saúde.
- Você pode deixar o estudo a qualquer momento se mudar de ideia.
Quem pode ser elegível?
To be considered for this study, you must be 18 years old or older. The study is open to both men and women.
Since this study is part of a larger research programme, there are specific guidelines that decide who can and cannot take part. These guidelines are carefully considered to make sure the study is safe for everyone involved and that the results are clear.
If you are interested, a member of the research team will explain these guidelines in detail and check if you meet all the necessary requirements for screening. They will ask questions about your health and medical history.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Você tem 18 anos ou mais?
- Do you have high blood pressure?
- Are you currently overweight or living with obesity?
- Você consegue comparecer a consultas regulares na clínica?
O que envolve a participação?
Taking part in this study would involve a series of visits to the clinic over a period of time. During these visits, you would have various health checks, such as measurements of your blood pressure, weight, and blood tests. You would be given either the study medicine (orforglipron) or a dummy pill (placebo) to take regularly, as instructed by the study team.
The specific number of visits and the total length of your participation would be explained fully by the study team during your initial conversations. There will also be follow-up appointments to monitor your health and how you are responding to the medication. All procedures, including medication doses and the duration of the study, will be carefully set out in the study plan.
Riscos e benefícios potenciais
Locations (99)
- Elite Clinical Studies, LLCCódigo postal verificadoPhoenix, Estados Unidos
- Valley Clinical Trials, Inc.Código postal verificadoCovina, United States
- Valley Clinical Trials, Inc.Código postal verificadoNorthridge, Estados Unidos
- Chase Medical Research, LLCCódigo postal verificadoWaterbury, United States
- Excel Medical Clinical TrialsCódigo postal verificadoBoca Raton, United States
- Care Access - BrandonCódigo postal verificadoBrandon, United States
- Northeast Research Institute - Downtown OfficeCódigo postal verificadoJacksonville, Estados Unidos
- Peace River Cardiovascular CenterCódigo postal verificadoPort Charlotte, United States
- East-West Medical Research InstituteCódigo postal verificadoHonolulu, United States
- Sinai Hospital Of BaltimoreCódigo postal verificadoBaltimore, Estados Unidos
- Ascension Saint Agnes Heart CareCódigo postal verificadoBaltimore, Estados Unidos
- Lucida Clinical TrialsCódigo postal verificadoNew Bedford, United States
Perguntas frequentes
O que é pressão alta?
High blood pressure, or hypertension, means your blood is pushing too hard against the walls of your arteries. Over time, this can damage your blood vessels and lead to serious health problems like heart disease or stroke.
What is 'obesity or overweight' in this study?
This refers to having a body weight that is higher than what is considered healthy for your height. The study will use specific measurements, like Body Mass Index (BMI), to determine this.
O que é um 'placebo'?
A placebo is a 'dummy' pill or treatment that looks exactly like the real medicine but contains no active drug. It helps researchers see if the real medicine is actually working or if improvements are due to other factors.
Saberei se estou recebendo o medicamento real ou o placebo?
No, neither you nor the study team will know whether you are receiving the active medicine or the placebo. This is to ensure the study results are fair and unbiased. This is called 'blinding'.
Posso parar de participar do estudo se eu quiser?
Yes, absolutely. Your participation is completely voluntary, and you can choose to leave the study at any time, for any reason, without it affecting your future medical care.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.